Intervention not reported
High‐ versus medium‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 237 participantsVery low
Findings
What do systematic reviews say?
2,908 questions · 3,101 findings · 509 reviews
No studies found 571 · 18.4%GRADE not reported 358 · 11.5%Very low 723 · 23.3%Low 854 · 27.5%Moderate 489 · 15.8%High 106 · 3.4%
Intervention not reported
Medium‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 160 participantsVery low
Intervention not reported
High‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 187 participantsVery low
Intervention not reported
High‐ versus medium‐ dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 187 participantsVery low
Intervention not reported
Medium‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 139 participantsVery low
Intervention not reported
High‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 187 participantsVery low
Intervention not reported
High‐ versus medium‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 187 participantsVery low
Intervention not reported
Medium‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted3 studies · 139 participantsVery low
Intervention not reported
High vs low dose Systolic blood pressure · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted1 study · 141 participantsVery low
Intervention not reported
High vs low dose Diastolic blood pressure · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review
- no estimate extracted1 study · 141 participantsVery low
First‐line chemotherapy vs BSC
Overall survival · patients with extensive SCLC without previous treatment
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 65 participantsVery low
First‐line chemotherapy vs BSC
Adverse effects · patients with extensive SCLC without previous treatment
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 65 participantsVery low
Intervention not reported
Overall survival · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy
The intervention may leads to lower overall survival (low certainty).
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyHR 0.73 [0.55, 0.96]2 studies · 542 participantsLow
Intervention not reported
Toxic death · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 542 participantsModerate
Intervention not reported
Adverse effects · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 542 participantsModerate
Intervention not reported
Quality of life · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy
The intervention may leads to higher quality of life (low certainty).
1 finding from 1 review
- Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes onlyRR 2.18 [0.05, 0.25]1 study · 141 participantsLow
Intervention not reported
Hospital length of stay (high‐risk surgical patients) · Adult patients in intensive care
1 finding from 1 review
- Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 503 participantsHigh
Intervention not reported
Cost of care (hospital charges, 1000s of US dollars) · Adult patients in intensive care
1 finding from 1 review
- Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 191 participantsLow
Intervention not reported
Combined mortality of all studies · Adult patients in intensive care
The intervention leads to higher combined mortality of all studies (high certainty).
1 finding from 1 review
- Pulmonary artery catheters for adult patients in intensive care 2013 · Cochrane Headline outcomes onlyRR 1.0113 studies · 5686 participantsHigh
Intervention not reported
Adherence · people with glaucoma or ocular hypertension
1 finding from 1 review
- Interventions for improving adherence to ocular hypotensive therapy 2013 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 902 participantsLow